More on BCYC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (7.2 Score)

Upcoming Events

- Earnings (5/1/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Bicycle Therapeutics Plc (NQ:BCYC)
Delayed: 5.19 -0.16 (2.99%)
Prev. Close $5.35  
Open$5.32 
52 Wk High$ 
52 Wk Low$ 
Day High$5.35 
Day Low$5.16 
P/E N/A  
EPS$ 
Volume274,366 

Friends, Peers and Foes (?): S1GE34, CATX, BCAX, BOLD, MAZE (more...)

Mar 4, 2026 12:45 PM Form SCHEDULE 13G/A BICYCLE THERAPEUTICS Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
Mar 3, 2026 05:40 PM Form SCHEDULE 13G BICYCLE THERAPEUTICS Filed by: Invus Global Management, LLC
Mar 3, 2026 05:28 PM Form SCHEDULE 13G/A BICYCLE THERAPEUTICS Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
Mar 3, 2026 05:25 PM Form SCHEDULE 13G/A BICYCLE THERAPEUTICS Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
Mar 2, 2026 04:06 PM Seres Therapeutics names Richard Kender as interim CEO
Mar 2, 2026 04:05 PM Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates
Feb 18, 2026 04:47 PM Form SCHEDULE 13G BICYCLE THERAPEUTICS Filed by: ARMISTICE CAPITAL, LLC
Feb 11, 2026 10:58 AM Form SCHEDULE 13G/A BICYCLE THERAPEUTICS Filed by: WESTFIELD CAPITAL MANAGEMENT CO LP
Feb 4, 2026 07:02 PM Form 4 BICYCLE THERAPEUTICS For: Feb 03 Filed by: Thompson Travis Alvin
Feb 3, 2026 07:07 AM Form 8-K BICYCLE THERAPEUTICS For: Jan 29
View All Articles

Entities mentioned with BCYC

View All Entities